Children with refractory systemic juvenile idiopathic arthritis–related lung disease had complete remission after stem cell ...

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to Rutgers Health researchers.

Children and adolescents with multiple sclerosis (MS) have a range of symptoms, signs, and diagnoses within five years before ...

Nine ICD-10 codes were seen more often in children with multiple sclerosis ... with controls without MS or those with juvenile idiopathic arthritis (JIA). The population-based, matched case ...

“Work can then begin to translate these findings into the clinic to improve the screening process for uveitis in children with juvenile idiopathic arthritis.” The Cluster Consortium is funded ...

A 14-year-old patient presented to the ED with a 12-month history of joint pains and a 2-month history of headaches and ...

Objective: To study infliximab and etanercept in the treatment of refractory juvenile idiopathic arthritis (JIA). Methods: In a non-randomised, prospective, open label study, 24 patients (mean age ...

Royal Liverpool Children's Hospital NHS Trust, Eaton Road, Liverpool L12 2AP, UK; gavin.cleary{at}talk21.com A 10 year old boy with juvenile idiopathic arthritis is described. He was treated with ...

Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...